RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790,947 | +31.9% | 34,494 | -5.2% | 0.00% | +100.0% |
| Q2 2023 | $599,758 | -64.2% | 36,371 | -61.2% | 0.00% | -75.0% |
| Q1 2023 | $1,674,213 | +170.1% | 93,846 | +340.9% | 0.00% | +300.0% |
| Q4 2022 | $619,761 | -83.7% | 21,283 | -88.1% | 0.00% | -94.1% |
| Q1 2021 | $3,802,000 | +567.0% | 178,757 | +833.1% | 0.02% | +466.7% |
| Q4 2020 | $570,000 | -6.7% | 19,158 | -32.0% | 0.00% | -25.0% |
| Q3 2020 | $611,000 | +166.8% | 28,192 | +174.9% | 0.00% | +100.0% |
| Q2 2020 | $229,000 | +358.0% | 10,257 | +346.3% | 0.00% | – |
| Q3 2019 | $50,000 | -93.8% | 2,298 | -92.2% | 0.00% | -100.0% |
| Q1 2019 | $806,000 | +1200.0% | 29,430 | +1180.7% | 0.00% | +300.0% |
| Q4 2018 | $62,000 | – | 2,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
| NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
| RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
| Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
| Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
| Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
| Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
| Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
| Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |